Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
about
Biomarkers in pancreatic adenocarcinoma: current perspectivesDNA studies using atomic force microscopy: capabilities for measurement of short DNA fragmentsFollicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcome.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluidsCirculating Cell-Free Tumour DNA in the Management of Cancer.Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis.Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancerCirculating nucleic acids in plasma and serum: diagnosis and prognosis in cancerAngiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer.Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese womenA self-powered, one-step chip for rapid, quantitative and multiplexed detection of proteins from pinpricks of whole bloodPrognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resectionDiagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Role of Circulating Cell-Free DNA in Cancers.Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Screening for ovarian cancer: imaging challenges and opportunities for improvement.Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression.Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer.PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma.Centrifugation-free extraction of circulating nucleic acids using immiscible liquid under vacuum pressure.Prognostic value of various subtypes of extracellular DNA in ovarian cancer patientsRole of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer
P2860
Q28072309-EA7F2A70-878A-4A9B-B512-EAD373E6CC48Q28080979-B338F529-EBE1-403B-A171-509F204C4DE4Q33849926-8A1BC443-EEEE-46D9-9D12-AF7C226A8ABAQ34426839-CBC29204-0AE0-4603-A9A4-56EAA79FF306Q35099257-3CB438E6-8503-40FC-AF0B-56E0D431FF04Q35814162-7E510CD1-22BA-4E97-8F7C-2ECB99ABD45EQ36037774-7557D317-BB34-44DE-B426-6B83217EBFBAQ36073981-6B932EBC-D2F7-4212-B276-7C407D5AD836Q36103228-09ECD3AB-6C93-4D8A-B180-40F7677F5B75Q36117667-DAF8D711-D712-486C-B5CB-56628C243037Q36199836-39986DB5-B2E3-481D-9AB4-18AC4BBB8374Q36256718-822A835D-55A0-478A-9D66-71DE3426842FQ36354286-3F76C828-878F-44E8-9F47-B567D511D08CQ36837116-C9052D82-3519-4163-83A7-FB8691B7021BQ37061376-E7999CC5-A360-44B5-8BB0-BD9CF85081B1Q37242412-FD5B8B20-C99D-4CB1-9E2B-92FB5879666CQ37715050-0CAB6FE7-EA97-4CA2-AF8F-614AF143408DQ38152782-B1892545-A101-4C59-8267-25CFC9903213Q38591963-D893AC59-2B58-4C0F-9788-B3F7C36CFE51Q40358645-037EE92E-82B5-4CE9-A56E-D4BC4C8BC623Q40706725-D2A7CAFC-EE99-4FA2-A36C-7DFE63DAC994Q40707142-1EA47383-056E-40D7-90F6-81FFD7619838Q41006936-F198286B-7943-406C-A4D2-5EEBC1265001Q43557526-218965AD-10D2-4D08-B129-9117AA6335AFQ47094357-560DE88D-CAE3-44F2-8639-E0110CE093AFQ47134018-896A5C7E-FD36-433A-9653-C01415CC63FCQ49826552-1C8BB40A-F5EE-40EF-BA44-1494148D97C1Q52431428-12921ACF-995A-461B-952F-8BFBD584124BQ52721890-DEBA9ACE-4B8D-4F48-B994-2024A7098312Q58702160-993FDB44-2234-4583-9CC7-54AB8360106CQ59233182-93AF4513-6F79-46C2-89B4-A78F866646FD
P2860
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@ast
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@en
type
label
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@ast
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@en
prefLabel
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@ast
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@en
P2093
P2860
P356
P1433
P1476
Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
@en
P2093
Andrew Godwin
Anil K Sood
Aparna A Kamat
Beth Y Karlan
David M Gershenson
Diana Dang
Diana Urbauer
Farideh Z Bischoff
Joe L Simpson
P2860
P304
P356
10.1002/CNCR.24997
P407
P577
2010-04-01T00:00:00Z